Thomas Seifert-Held - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Thomas Seifert-Held

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Plos One|November 14, 2013

Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million peopleFahmy Aboul-Enein, Thomas Seifert-Held, Simone Mader, et al.

Brain : a Journal of Neurology|March 8, 2022

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 diseaseThomas Grüter, Franziska E Möllers, Anja Tietz, et al.

Neurology|August 12, 2021

Frequency and Characterization of Movement Disorders in Anti-IgLON5 DiseaseCarles Gaig, Yaroslau Compta, Anna Heidbreder, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Plos One|November 14, 2013

Brain : a Journal of Neurology|March 8, 2022

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 diseaseThomas Grüter, Franziska E Möllers, Anja Tietz, et al.

Neurology|August 12, 2021

Frequency and Characterization of Movement Disorders in Anti-IgLON5 DiseaseCarles Gaig, Yaroslau Compta, Anna Heidbreder, et al.

Pageof 4